AIA
Avalon Investment & Advisory’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-753
| Closed | -$214K | – | 320 |
|
2022
Q1 | $214K | Sell |
753
-35,465
| -98% | -$10.1M | 0.01% | 306 |
|
2021
Q4 | $13.6M | Sell |
36,218
-6,204
| -15% | -$2.34M | 0.34% | 88 |
|
2021
Q3 | $17.5M | Buy |
42,422
+2,097
| +5% | +$865K | 0.41% | 75 |
|
2021
Q2 | $14.9M | Sell |
40,325
-18,468
| -31% | -$6.83M | 0.33% | 99 |
|
2021
Q1 | $17M | Buy |
58,793
+232
| +0.4% | +$67.2K | 0.39% | 94 |
|
2020
Q4 | $14.6M | Buy |
58,561
+535
| +0.9% | +$134K | 0.3% | 104 |
|
2020
Q3 | $13.1M | Sell |
58,026
-2,530
| -4% | -$573K | 0.29% | 108 |
|
2020
Q2 | $10.6M | Sell |
60,556
-7,408
| -11% | -$1.29M | 0.24% | 117 |
|
2020
Q1 | $8.58M | Buy |
+67,964
| New | +$8.58M | 0.22% | 121 |
|